Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Dako Denmark A/S
Dako Denmark A/S
Activities:
Manufacturing
Analysis
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Dako expands companion diagnostics collaboration with Amgen
Will pool their knowledge of drug diagnostic R&D and companion diagnostics
You need to be a subscriber to read this article.
Click here
to find out more.
Regulatory
Reimbursment issues hinder future development of personal therapies
The development of more targeted therapies is moving apace, but are the payers prepared for it? Dr Sarah Houlton looks at the progress of personalised medicines
Finance
Agilent to buy Dako for US$2.2bn
All-cash deal is largest in Agilent’s history
Analysis
FDA approves Dako diagnostic kit
Aid for breast cancer patients for whom Herceptin is being considered
Research & Development
Dako enters collaboration with Bristol-Myers Squibb
On the development of pharmacodiagnostic tests
Subscribe now